Jane Gross
Directeur/Bestuurslid bij ATYR PHARMA, INC.
Vermogen: 10 380 $ op 31-05-2024
Actieve functies van Jane Gross
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATYR PHARMA, INC. | Directeur/Bestuurslid | 28-06-2019 | - |
Independent Dir/Board Member | 28-06-2019 | - | |
BRIACELL THERAPEUTICS CORP. | Directeur/Bestuurslid | 01-11-2021 | - |
Independent Dir/Board Member | 01-11-2021 | - | |
Washington Biotechnology & Biomedical Association | Directeur/Bestuurslid | - | - |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Jane Gross
Eerdere bekende functies van Jane Gross
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
APTEVO THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2016 | 14-09-2021 |
EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01-07-2011 | 01-08-2016 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-02-2009 | 01-06-2010 |
Opleiding van Jane Gross
University of California, Berkeley | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Canada | 3 |
Operationeel
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
ATYR PHARMA, INC. | Health Technology |
EMERGENT BIOSOLUTIONS INC. | Health Technology |
APTEVO THERAPEUTICS INC. | Health Technology |
BRIACELL THERAPEUTICS CORP. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Jane Gross
- Ervaring